IOBT IO Biotech, Inc. Net earnings per share growth this year

IOBT (IO Biotech, Inc.) - company brandmark

IO Biotech, Inc. (IOBT) maintains scientific authority in immuno-oncology, confirming the effectiveness of its efforts to combat the tumor environment. The YoY net income per share growth rate illustrates current resilience, with the value stabilizing at 34.20. While the Danish laboratory develops innovative vaccines against metastases, the lack of commercial products leaves the company dependent on external investments rather than its own cash flow.

IO Biotech (IOBT): Net earnings per share growth this year from 07/04/2022 to 04/18/2026

Analytical breakdowns and data insights for company IO Biotech, Inc. (IOBT)

- current quotes and average value forecast:
Market Chart IO Biotech Inc|IOBT - Price Target Chart
- market capitalization data:
Market Valuation IO Biotech Inc.|IOBT - Total Company Value
- company book value details:
Accounting Value per Share IO Biotech|IOBT - Company Net Assets|Market Capitalization to Book Value Ratio iobiotech.com|IOBT - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio IO Biotech, Inc.|IOBT - Long-Term Debt to Equity|Current Liabilities to Capital iobiotech.com|IOBT - Company Total Debt|Debt to Net Assets IO Biotech Inc.|IOBT - Company Long-Term Liabilities|Amount of Current Liabilities IO Biotech|Intermediate Coverage Ratio iobiotech.com
- net income and valuation ratios data:
IOBT - Net Profit|Expected Net Profit IO Biotech, Inc.|IOBT - Price to Earnings Ratio|Future Price to Earnings Multiple IO Biotech Inc.|IOBT - PEG Multiple|EV/EBITDA Multiple IO Biotech Inc.|IOBT - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months IO Biotech|IOBT - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months iobiotech.com|IOBT - Earnings growth in current year|Consensus forecast of earnings per share growth for next year IO Biotech, Inc.
Summary company analysis:IOBT (IO Biotech Inc)
Brand item of IO Biotech Corp

This indicator measures the annual dynamics of net earnings per share, reflecting the efficiency of capital generation relative to the volume of issuance. By analyzing the comparable year-over-year growth rate of earnings per share, an investor assesses the fundamental stability of the business, which is critical for IO Biotech, Inc. (IOBT) due to operating losses, reliance on secondary offerings, and high risks of clinical trial failures for its vaccines.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year Immunocore PLC|Net earnings per share growth this year Janux Corp (JANX)|Earnings per share growth in current year Arcus Biosciences, Inc. (RCUS)|Net earnings per share growth this year zymeworks.com ZYME|Tango Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Iovance Biotherapeutics Inc IOVA|IMTX - Earnings per share growth in current year|XNCR (Xencor Inc.) - Earnings per share growth this year|Compass Therapeutics (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year replimune.com (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year STRO (Sutro Biopharma, Inc.)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma, Inc.|ALX Oncology (ALXO) - Earnings per share growth in current year|Cue Biopharma Inc. - Earnings per share increase in current year|PDSB (PDS Biotech) - Earnings growth in current year|Earnings growth in current year Sonnet BioTherapeutics Holdings Inc.|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|NextCure Corporation (NXTC) - Earnings per share growth rate in current year|Leap Tx - Earnings growth in current year|Expected net earnings per share growth this year Intensity Therapeutics INTS|senseibio.com (SNSE) - Earnings per share growth in current year|Earnings per share growth rate in current year Theriva Biologics Inc (TOVX)|Net earnings per share growth this year GRTS|KA: Earnings per share increase in current year|Earnings growth in current year NEXI|Earnings per share growth in current year TSBX (turnstonebio.com)|Earnings growth in current year VCNX (Vaccinex)|Expected net earnings per share growth this year Harpoon Therapeutics Inc (HARP)